Pennsylvania's cannabis legislative landscape is more active than ever. The historic House passage of HB 1200 in May 2025 demonstrated that recreational legalization has majority support in at least one chamber. Multiple bills addressing recreational legalization, medical program expansion, and regulatory reform are in various stages of the legislative process.
Recreational Legalization Bills
HB 1200 (Krajewski/Frankel) — State-Run Stores
Status: Passed House 102-101 (May 7, 2025). Tabled by Senate Law & Justice Committee 7-3 (May 13, 2025).
The first recreational cannabis bill to ever pass a chamber of the PA General Assembly. Key provisions:
- State-run retail through the PA Liquor Control Board
- 12% excise tax plus 6% state sales tax (18% combined)
- Social equity and community reinvestment provisions
- Existing medical dispensaries could apply for dual-use licenses
The state-store model was strategically designed to appeal to Pennsylvania's political culture, mirroring the existing state liquor store system. Despite passing the House, the bill was dead on arrival in the Republican-controlled Senate.
SB 120 (Laughlin/Street) — Private Retail, Bipartisan
Status: In Senate Law & Justice Committee. No floor vote scheduled.
The most significant bipartisan effort, co-sponsored by Republican Dan Laughlin and Democrat Sharif Street:
- Private retail model with licensed dispensaries
- New independent Cannabis Control Board as regulator
- 8% excise tax plus 6% sales tax (14% combined)
- Broader market participation than HB 1200
- Explicit social equity licensing provisions
SB 120 represents the potential compromise position — lower tax rate than HB 1200, private market instead of state stores, and bipartisan sponsorship. Senator Laughlin has described his caucus as "very divided" on the issue.
HB 20 (Kinkead/Major) — House Companion to SB 120
Status: In House committees.
The House companion to SB 120, mirroring its private retail framework. Sponsored by Representative Emily Kinkead (D) and others. Provides a vehicle for the private-retail approach in the House if SB 120 advances in the Senate.
| Bill | Status | Key Feature |
|---|---|---|
| HB 1200 (Krajewski/Frankel) | Passed House 102-101 (May 7, 2025), tabled by Senate committee May 13 | State-run stores via Liquor Control Board, 12% excise + 6% sales |
| SB 120 (Laughlin/Street) | In Senate Law & Justice Committee (no floor vote scheduled) | Private retail model, Cannabis Control Board, 8% excise + 6% sales (14%) |
| HB 20 (Kinkead/Major) | House companion to SB 120 | Same private retail framework |
Gov. Shapiro projects $729M first-year revenue. 68% voter support. But Republican Senate (27/50 seats) is the obstacle. Realistic timeline: 2027+ for first rec sales.
Medical Program Bills
HB 533 — "Any Serious Condition" Qualification
Status: Pending in House Health Committee.
Would replace the current list of 24 specific qualifying conditions with broader language authorizing physicians to certify patients for "any serious condition" where cannabis therapy is warranted. This would:
- Give physicians broader clinical discretion
- Eliminate the need for legislative action to add new conditions
- Align PA with states like Oklahoma and Missouri
SB 49 — Medical Program Enhancements
Status: In Senate committees.
Proposed updates to the medical cannabis program including:
- Potential expansion of product forms (including edible sales at dispensaries)
- Streamlined renewal processes
- Reduced barriers for patient access
SB 76 — Additional Medical Reforms
Status: In Senate committees.
Further medical program modifications addressing:
- Caregiver access improvements
- Practitioner registration streamlining
- Patient protections and program administration updates
Federal Developments
Federal Rescheduling
The ongoing federal rescheduling process (moving cannabis from Schedule I to Schedule III) would have significant implications for Pennsylvania's cannabis industry if completed:
- Section 280E relief: Eliminating the tax provision that prevents cannabis businesses from deducting standard business expenses on federal returns
- Banking access: Easing federal restrictions on banking services for cannabis companies
- Research facilitation: Reducing barriers to clinical cannabis research, which would benefit PA's clinical registrant program
Federal rescheduling would not legalize recreational cannabis — state programs would continue under state authority.
2026 Election Outlook
The 2026 elections are the most significant variable in Pennsylvania's cannabis policy future:
- All 203 House seats on the ballot
- 25 of 50 Senate seats on the ballot
- Governor's race (Shapiro term-limited; successor's position on cannabis matters)
- 68% voter support for legalization provides strong electoral incentive
If the 2026 elections produce a Senate that is either more Democratic or includes more Republican members who support legalization, recreational cannabis legislation could advance in 2027. The earliest realistic date for first recreational sales would be late 2027 to 2028.
How to Track Legislation
- PA General Assembly — Bill Search
- Find Your Legislator
- Follow advocacy organizations for legislative updates and action alerts
For in-depth cannabis education, dosing guides, safety information, and research summaries, visit our partner site TryCannabis.org
Related on this site: Pennsylvania Cannabis License & B..., Pennsylvania Cannabis Legalization Ti..., Send a Message.